The Development of Investigator-Initiated Clinical Trials in Surgical Oncology

Hannah G McDonald1, Emily B Cassim1, Megan M Harper1

  • 1Division of Surgical Oncology, University of Kentucky, 800 Rose Street C224, Lexington, KY 40508, USA.

Insights

Surgical oncologists can lead investigator-initiated trials (IITs) to address clinical gaps. Developing these oncology trials involves regulatory navigation, funding, and enrollment, highlighting IITs' crucial role.

Area of Science:

  • Oncology
  • Clinical Trials
  • Surgical Oncology

Background:

  • Investigator-initiated trials (IITs) address unmet clinical needs identified by principal investigators.
  • Surgical oncologists are well-positioned to lead IITs due to their clinical expertise and research experience.

Purpose of the Study:

  • To explore the process, methodology, and challenges of developing IITs by surgical oncologists.
  • To emphasize the significance of IITs in advancing oncology research and patient care.

Main Methods:

  • Review of the multifaceted process of IIT development.
  • Identification of key steps: regulatory navigation, funding acquisition, and participant enrollment.

Main Results:

  • IIT development is complex, requiring careful planning and execution.
  • Surgical oncologists possess the necessary skills to lead these critical research endeavors.

Conclusions:

  • IITs are vital for addressing critical gaps in oncology.
  • Surgical oncologists play a pivotal role in driving innovative clinical research through IITs.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K